Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

December 22, 2022

Biotechnology

SciSparc to Acquire AutoMax

April 11, 2024
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

April 11, 2024
MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary

April 11, 2024
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection

April 11, 2024